Overall, our study provided the initial data regarding the potential mechanisms of CLDN4 contributing to the recurrence of MPE in advanced NSCLC, while further in‐depth experiments were required to perform to validate its specific mechanisms. This evidence concerns the gene CLDN4 and non-small cell lung carcinoma.